No Data
No Data
Volpara to Delist After Court Approves Acquisition by Lunit
The New Zealand High Court has granted final approval for Volpara Health Technologies' (ASX:VHT) acquisition by Lunit Inc., an AI-powered cancer screening and treatment company, according to a Friday
Volpara Health Technologies Secures Approval for Lunit's Proposed Takeover
Volpara Health Technologies (ASX:VHT) secured shareholder approval for the proposed takeover of the breast cancer detection firm by cancer diagnostics technology company Lunit (KRX:328130) via a schem
Volpara Shareholder Meeting to Be Held on April 12 >328130.SE
Volpara Shareholder Meeting to Be Held on April 12 >328130.SE
Update On Lunit's Acquisition Of Volpara: New Zealand High Court Initial Approval Secured VHT.AU
Update On Lunit's Acquisition Of Volpara: New Zealand High Court Initial Approval Secured VHT.AU
Lunit to Take Over Volpara Health; Lunit Shares Decline 4%
Lunit (KOSDAQ:328130), a South Korea-based AI-powered solutions for cancer diagnostics and therapeutics provider, plans to acquire Volpara Health (ASX:VHT), a New Zealand-based breast cancer solution
Lunit's Bid for Volpara Should Get Deal Done -- Market Talk
2328 GMT - Lunit's US$193 million bid for Volpara looks modest to Bell Potter analyst John Hester, who nonetheless thinks it should be enough to get the deal done. While the A$1.15 offer represents a
No Data